![Claudia Riedl](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 313 $ al 31/08/2026
Dr. Claudia Riedl is an Independent Non-Executive Director at Vivoryon Therapeutics NV.
She is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Riedl was previously employed as a Head-Corporate Communications & Investor Relations by MorphoSys AG.
She received her doctorate degree from Technische Universität München.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 1.000 ( 0 % ) | 1 313 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Director/Miembro de la Junta | 01/01/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| MORPHOSYS AG | Public Communications Contact | 01/01/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Technische Universität München
 Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
